Biotest AG announced that the supervisory board of the company, in it's meeting held on July 9, 2014, has appointed Dr. Bernhard Ehmer as member of the executive board effective November 1, 2014. As of January 1, 2015, Ehmer will take over the role as CEO from Prof. Dr. Gregor Schulz, whose appointment will then end after 12 years due to reaching the age limit. In his last position as CEO & President of Imclone Systems Corp.

his focus has been the successful clinical development and market preparation of biologic pharmaceuticals. Besides Dr. Bernhard Ehmer as CEO, Dr. Michael Ramroth (CFO) and Dr. Georg Flo, (COO) will continue to be members of the executive board of the company.